CLOV vs CNC
CLOV: Clover Health combines Medicare Advantage insurance with a proprietary, AI-driven clinical decision-support platform designed to improve health outcomes and manage costs for Medicare beneficiaries. CNC: The nation's largest managed care insurer for underserved populations, connecting 27.6 million Medicaid, Medicare, and Marketplace members with affordable healthcare and social support services.
Side-by-side fundamentals
| Metric | CLOV | CNC | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $4.67 | $65.89 | |
| Market cap as of 2026-07-23 | $2.5B | $33.0B | |
| PEG as of 2026-07-23 | -0.35 | n/a | |
| Net margin as of 2026-07-23 | -2.6% | -3.3% | CLOV higher |
| Gross margin as of 2026-07-23 | n/a | +7.2% | |
| Operating margin as of 2026-07-23 | -2.6% | -3.7% | CLOV higher |
| ROE as of 2026-07-23 | -17.1% | -28.7% | CLOV higher |
| ROA as of 2026-07-23 | -9.6% | -7.9% | CNC higher |
| Debt / equity as of 2026-07-23 | 0.00 | 0.76 | CLOV lower |
| Revenue growth (YoY) as of 2026-07-23 | +48.8% | +17.0% | CLOV higher |
| Revenue CAGR (3y) SEC XBRL | +20.6% | +10.5% | CLOV higher |
| Beta as of 2026-07-23 | 2.52 | 1.09 | |
| 1-year return as of 2026-07-22 close | +45.0% | +136.2% | CNC higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.